DLL3-targeted therapies, including T-cell engagers and CAR T-cell therapies, show promise in SCLC treatment, with ongoing trials demonstrating efficacy and safety. The DeLLphi-300 trial reported a ...

In the U.S., only 16% of people eligible for lung cancer screening are getting the lifesaving scan, and 23% of lung cancer patients receive chemotherapy and/or radiation before undergoing full ...

Once in the brain, lung cancer cells can plug themselves into the electrical circuitry there and grow, a study of mice shows. The results, published September 10 in Nature, highlight the deep and ...

Please provide your email address to receive an email when new articles are posted on . Guidelines are needed for populations of never-smokers who have increased risk for lung cancer. Asian women who ...

AURORA, Colo. (KDVR) — Dr. Ross Camidge is the director of the Thoracic Oncology Department at the University of Colorado Cancer Center on the Anschutz Medical Campus. “We’ve led or contributed to ...

After climbing in the business world, she received a dire diagnosis, spurring her to found leading nonprofit groups to promote early detection and research. By Sam Roberts Bonnie Addario, a lung ...

Advances are reshaping treatment for small cell lung cancer, with immunotherapy and emerging options offering hope for longer survival and potential cures. Immunotherapy is changing treatment ...

Copyright: © 2025 Elsevier Ltd. Published by Elsevier Ltd. Speaking on behalf of a large international group of researchers, Alexander Drilon (Memorial Sloan ...

Visually assessed pulmonary emphysema independently predicted modestly elevated all-cause mortality risk over 25 years of follow-up in patients with a history of smoking. After controlling for other ...

Combining Summit Therapeutics and Akeso’s closely watched cancer drug with chemotherapy didn’t help people with lung cancer live longer than chemo alone in a late-stage study, raising doubts whether ...

A common artificial sweetener could make cancer treatments less effective, a new study has found. Sucralose, a sweetener found in many diet sodas, low-calorie snacks and powdered sugar substitutes, ...

Partners Daiichi Sankyo and Merck & Co. are sharing new phase 2 data for their investigational antibody-drug conjugate, findings the pair think will help score accelerated approval in pretreated small ...